FDA Inspection 1121881 — Hospira, Inc.
The FDA completed an inspection of Hospira, Inc. on February 27, 2020 in Lake Forest, IL. The inspection was classified NAI (No Action Indicated — no objectionable conditions were found). Product area: Drugs.
Inspection Details
- Classification
- No Action Indicated (NAI) (NAI)
- End Date
- February 27, 2020
- Fiscal Year
- 2020
- Product Type
- Drugs
- Project Area
- Drug Quality Assurance
- Location
- Lake Forest, IL (United States)